FDA and FTC Go After Firms Selling Unproven Opioid Treatments

Drug Industry Daily
The Food and Drug Administration teamed up with the Federal Trade Commission to issue joint warning letters to 11 marketers and distributors of opioid cessation products, for illegally marketing products with unproven claims of treating opioid addiction.

To View This Article:


Subscribe To Drug Industry Daily